Article citationsMore>>
Park, J., Ko, Y.S., Yoon, J., Kim, M.A., Park, J.W., Kim, W.H., Choi, Y., Kim, J.H., Cheon, Y. and Lee, B.L. (2014) The Forkhead Transcription Factor FOXO1 Mediates Cisplatin Resistance in Gastric Cancer Cells by Activating Phosphoinositide 3-Kinase/Akt Pathway. Gastric Cancer, 17, 423-430.
has been cited by the following article:
-
TITLE:
Evaluating the p-FOXO1/FOXO1 Ratio: An Alternative Strategy for Endometrial Cancer Diagnosis
AUTHORS:
Mohsen Korani, Soudabeh Fallah
KEYWORDS:
Endometrial Cancer, FOXO1, p-FOXO1, Transcription Factor
JOURNAL NAME:
International Journal of Clinical Medicine,
Vol.6 No.3,
March
26,
2015
ABSTRACT:
Background: The FOXO subfamily of Forkhead transcription factors plays a central role in pro-moting expression of proapoptotic and cell cycle regulatory genes. FOXO1 expression has an im-portant role in human endometrium homeostasis. Therefore, reduced FOXO1 protein and its inactivation by phosphorylation might, play a role in progression of human endometrial cancer. Methods: Current study was designed to investigate the changes of the FOXO1, phosphorylated-FOXO1 (p-FOX1) proteins levels and the p-FOXO1/FOXO1 ratio in 30 patients with endometrial cancer and 20 subjects with normal endometrium, surgically using excised human endometrial tissue specimens, quantitative real time PCR and western blot methods. Results: FOXO1 protein level in patients with endometrial cancer significantly reduced in comparison with control group (0.17 ± 0.15 vs. 1 ± 0.14; p
Related Articles:
-
Knox Kwon
-
Noman Ali, Muhammad Asim, Raheel Asghar, Awais Amin, Muhammad Saif Ur Rahman
-
José Paulo Freire, Maria Emilia Oliveira, Maria Conceição Crujo, Ana Rute Fernandes, José Crespo Mendes de Almeida, Henrique Bicha Castelo
-
Tao Li, Meiha Leong, Jing Yuan, Juan Li, Lin Chen
-
Fabrizio Romano, Fabio Uggeri, Luca Nespoli, Luca Gianotti, Mattia Garancini, Matteo Maternini, Angelo Nespoli, Franco Uggeri